NGM Biopharmaceuticals Inc (DELISTED) (NGM:DL)
1.54
0.00 (0.00%)
USD |
NASDAQ |
Apr 05, 16:00
NGM Biopharmaceuticals Shares Outstanding: 83.46M for March 5, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
March 05, 2024 | 83.46M |
February 22, 2024 | 83.46M |
December 31, 2023 | 82.91M |
October 30, 2023 | 82.72M |
September 30, 2023 | 82.72M |
July 31, 2023 | 82.72M |
June 30, 2023 | 82.71M |
May 01, 2023 | 82.36M |
March 31, 2023 | 82.06M |
March 17, 2023 | 82.06M |
March 02, 2023 | 82.05M |
February 22, 2023 | 82.05M |
December 31, 2022 | 81.88M |
October 31, 2022 | 81.73M |
September 30, 2022 | 81.71M |
August 01, 2022 | 80.37M |
June 30, 2022 | 79.46M |
May 02, 2022 | 79.26M |
March 31, 2022 | 78.09M |
March 25, 2022 | 78.09M |
March 10, 2022 | 78.06M |
February 23, 2022 | 78.05M |
December 31, 2021 | 77.96M |
November 01, 2021 | 77.71M |
September 30, 2021 | 77.64M |
Date | Value |
---|---|
August 02, 2021 | 77.34M |
June 30, 2021 | 77.31M |
May 03, 2021 | 77.02M |
April 16, 2021 | 76.96M |
April 01, 2021 | 76.91M |
March 31, 2021 | 76.91M |
March 10, 2021 | 76.69M |
January 08, 2021 | 75.07M |
January 04, 2021 | 69.74M |
December 31, 2020 | 70.59M |
November 09, 2020 | 69.02M |
September 30, 2020 | 68.93M |
August 07, 2020 | 68.83M |
June 30, 2020 | 68.74M |
May 07, 2020 | 68.14M |
March 31, 2020 | 67.94M |
March 23, 2020 | 67.76M |
March 12, 2020 | 67.75M |
December 31, 2019 | 66.96M |
November 08, 2019 | 66.65M |
September 30, 2019 | 66.16M |
August 09, 2019 | 66.04M |
June 30, 2019 | 66.04M |
May 10, 2019 | 66.02M |
April 04, 2019 | 64.99M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
66.04M
Minimum
Jun 30 2019
83.46M
Maximum
Feb 22 2024
76.14M
Average
77.68M
Median
Shares Outstanding Benchmarks
Catalent Inc | 180.98M |
AIM ImmunoTech Inc | 51.28M |
Perspective Therapeutics Inc | 67.41M |
Protalix BioTherapeutics Inc | 73.32M |
Armata Pharmaceuticals Inc | 36.15M |